Medline Inc.
MDLN | NASDAQ
$32.12
+$0.12 (+0.37%)
At close: Oct 30, 2026, 4:00 PM ET
$32.44
+$0.32 (+1.00%)
Pre-market:
Nov 2, 2026, 8:39 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | 28.43B | 25.51B | 23.23B | 21.45B |
Cost of Revenue | 20.91B | 19.22B | 18.01B | 16.89B |
Gross Profit | 7.52B | 6.29B | 5.22B | 4.56B |
Operating Income | 2.21B | 2.23B | 1.44B | 870M |
Interest Income | n/a | 280M | 237M | 27M |
Pretax Income | 1.25B | 1.25B | 264M | 10M |
Net Income | 1.16B | 1.2B | 234M | -25M |
Selling & General & Admin | 4.52B | 4.04B | 3.81B | 3.62B |
Research & Development | n/a | 67M | 60M | 58M |
Other Expenses | 782M | -42M | -88M | 11M |
Operating Expenses | 5.31B | 4.07B | 3.78B | 3.69B |
Interest Expense | 812M | 1.31B | 1.38B | 911M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 26.22B | 23.28B | 21.79B | 20.58B |
Income Tax Expense | 91M | 46M | 30M | 35M |
Shares Outstanding (Basic) | 812M | 787.12M | 787.12M | 787.12M |
Shares Outstanding (Diluted) | 812M | 787.12M | 787.12M | 787.12M |
EPS (Basic) | 1.43 | 1.52 | 0.30 | -0.03 |
EPS (Diluted) | 1.43 | 1.52 | 0.30 | -0.03 |
EBITDA | 1.95B | 3.53B | 2.59B | 1.85B |
EBIT | 1.25B | 2.56B | 1.64B | 921M |
Depreciation & Amortization | 704M | 977M | 951M | 933M |
Add to Watchlist
Select watchlists to add or remove MDLN